Gov. Bullock visits with Bozeman pharmaceutical researchers


BOZEMAN, Mont. - A Bozeman-based pharmaceutical company announced Friday it's talking with the FDA about a possible vaccine for norovirus.

NBC Montana reported last year how Ligocyte Pharmaceuticals was acquired by Takeda Pharmaceuticals of Japan. The company is planning to expand in Bozeman.

The new vaccine is in clinical trials, and developers are meeting with the FDA.

Gov. Steve Bullock look a tour of the lab Friday and talked with researchers to learn more about the vaccine.

"Right here in this building could end up essentially the vaccine that takes care of 70 million people in the U.S. alone -- 200,000 kids dying each year and what they are working on here can change that," said Bullock.

According to the Centers for Disease Control, norovirus inflames the stomach and intestines. Symptoms include nausea, vomiting, diarrhea and severe stomach pains.

Norovirus is the most common cause of food borne illness and is responsible for 21 million illnesses and 70,000 hospitalizations each year in the United States.

Proper hand washing is the most effective way to prevent its spread.

More Stories